Tìm kiếm
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
2017 UNODC World Drug Report
Now in its 20th year of publication, the UNODC World Drug Report for 2017 is now available.
It consists of 5 accessible booklets:
Booklet 1 provides a summary of the subsequent 4 booklets. It also discusses the policy implications of the...
Alcohol Interventions in Primary Care Settings: What Works, What Doesn’t and What's Next?
This week saw the seminar launch at Edinburgh’s Royal College of Physicians of two key reports on alcohol interventions in primary care settings published by the Scottish Health Action on Alcohol Problems (SHAAP) in collaboration with the U...
Mortality Risk During and After Opioid Substitution Treatment
ABSTRACT
Objective
To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after...
Life in Recovery from Addiction in Canada
The Canadian Centre on Substance Use and Addiction (CCSA) has recently teamed up with the National Recovery Advisory Committee to produce the first Canadian survey of people in recovery from drug addiction and/or alcoholism.
The findings...
European Drug Report 2017
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has recently released its European Drug Report for 2017. The document offers an overview of the drug situation across the continent. It covers drug supply and use as well...
Field Guide to Drug Demand Reduction Program Development, 2nd ed.
The Field Guide to Drug Demand Reduction (DDR) Development is an annual publication by the U.S. Department of State primarily for its Embassy personnel abroad to guide in the development of substance use prevention and treatment programming...
Community Convening Guide: Substance Use Prevention, Screening, and Early Intervention
A key objective of Facing Addiction’s Action Agenda is to spread the awareness and adoption of youth prevention activities in your communities, examples of which include evidence-based prevention programming highlighted in the 2016 U.S...
The Societal Cost of Heroin Use Disorder in the United States
ABSTRACT
Objective
Heroin use in the United States has reached epidemic proportions. The objective of this paper is to estimate the annual societal cost of heroin use disorder in the United States in 2015 US dollars.
Methods
An analytic...
A Growing Issue: An Increased Number Are Entering Drug Treatment for Cannabis Use Across Europe
New research published in the journal European Addiction Research paints a picture of drug treatment services for cannabis-related problems between 2003 – 2014 across 22 European countries.
Notably, it suggests that, on the whole, during...
Effectiveness Bank Matrix Bite: Managing Coerced Alcohol Treatment
Key studies on the role of management in the treatment of problem drinking in criminal justice settings and/or to safeguard the community. Just as for practitioners, for managers the challenge is to extract therapeutic benefit out of a...
Prevention and Treatment for Drug Use in Rural Settings
The United Nations Office on Drugs and Crime (UNODC) has recently published what the organisation describes as ‘an awareness-raising tool’ aimed at policy-makers, public health officials, local authorities and other stakeholders.
Its...
High-Risk Drug Use and New Psychoactive Substances
‘High-risk drug use and new psychoactive substances’, a new report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), takes a look at the emergence of more problematic forms of new psychoactive substance use among a...
For Whom Does Prison-Based Drug Treatment Work? Results from a Randomized Experiment
For the first time in a prison setting, a randomised trial has rigorously compared intensive residential therapeutic community treatment to outpatient counselling. Confounding expectations, the US prison for problem drug users which hosted...
Treatment for Opioid Use Disorder: What's There to Learn?
This misuse of prescription opioids is a major public health challenge. Buprenorphine-naloxone (bup-nx) is typically used to treat opioid use disorders. However, the drug’s clinical trial primarily involved heroin users. It was therefore...
A Possible New Treatment for Alcohol Disorders?
New research published in the journal Biological Psychiartry points to a novel way for the treatment of alcoholism. This would look to reduce motivation for drinking instead of altering the effects of alcohol, itself. Indeed, the study...
How Do We Tackle the Opioid Epidemic?
The over-prescription of opioids is a significant public health issue in the United States. For example, opioids are often prescribed for minor injuries unnecessarily. This, in turn, increases the risk of addiction.
New research presented...
Effectiveness Bank Matrix Bite: What If the Therapist ... Is Also the Jailer?
A cell in the Alcohol Treatment Matrix. In an extreme form, the title poses the dilemma for alcohol treatment staff who may also be (seen as) working for authorities whose main role is to control or punish the ‘client’ or who may be...
Technology and Smoking Cessation: Are Personalised Emails Effective for Would-be Quitters?
A new American Cancer Society study published in the journal Tobacco Control suggests that regularly receiving personalised emails with tips for quitting amongst other information could be as effective at reducing the rate of smoking as...
More Treatments on Deck for Alcohol Use Disorder
Thirteen years have passed since the US Food and Drug Administration (FDA) last approved a new medication to help the nation’s millions of people with alcohol use disorder (AUD) stop or moderate their drinking.
Only 3 such formulations...
Do α2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal?
Study Selection
This systematic review included randomized controlled clinical trials that compared the administration of an α2-adernergic agonist with other interventions such as placebo or methadone to reduce symptoms of opioid...